MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Development of a health-related quality-of-life (HR-QoL) questionnaire for hereditary spastic paraplegia (HSP) patients and caregivers.

J. Malina, E-M. Hüßler, B. Schröder, N. Wiesenberg, T. Kühl, S. Klebe (Essen, Germany)

Meeting: 2023 International Congress

Abstract Number: 1915

Keywords: Non-motor Scales

Category: Quality Of Life/Caregiver Burden in Movement Disorders

Objective: The aim of this project is to develop and validate a health-related quality-of-life (HR-QoL) questionnaire, in a patient and a caregiver version, specific for hereditary spastic paraplegia (HSP). The questionnaire should be applicable in both research and clinical practice as a standardized patient-reported outcome measure (PROM).

Background: HSP is a group of rare genetic diseases, mainly characterised by lower limb weakness and spasticity due to degeneration of the corticospinal tract. The “Spastic paraplegia rating scale” (SPRS) is being broadly used as a validated clinical outcome parameter. However, to quantify the disease impact on patients’ daily lives and to measure treatment effectiveness from patients’ perspective, PROMs are also necessary. A validated PROM specific to HSP does not exist yet.

Method: Semi-structured guided interviews were conducted with 36 patients with different disease severities according to the SPRS and 18 caregivers. Based on qualitative data analysis pilot questionnaires were developed and sent to 91 HSP-households. After pilot-item analysis modified questionnaires were forwarded to HSP patients organizations for main validation. To confirm reliability, the questionnaires were resent two weeks later. To confirm specificity for HSP, correlation to EQ-5D-5L was examined. Exploratory factor analysis (EFA) was conducted to reveal the underlying structure.

Results: The pilot-questionnaires contained 45 items each. The first validation was conducted on the responses of 65 patients and 57 caregivers and led to the improved questionnaires with 28 Items each. The main validation was performed on 237 patient und 55 caregiver responses. After EFA 25 items in 5 domains remained. Statistical results were resilient with Cronbach’s alpha > 0.8 and test-retest correlation > 0.8. The correlation to EQ-5D-5L was 0.49. The correlation between patients’ and their caregivers’ responses was 0.75.

Conclusion: High response rates of the pilot questionnaires as well as large number of patient responses in the main validation study underline the importance of the HR-QoL-assessment. The questionnaire will be an integral component for future clinical trials, natural course studies and follow-up visits in clinical practice.

To cite this abstract in AMA style:

J. Malina, E-M. Hüßler, B. Schröder, N. Wiesenberg, T. Kühl, S. Klebe. Development of a health-related quality-of-life (HR-QoL) questionnaire for hereditary spastic paraplegia (HSP) patients and caregivers. [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/development-of-a-health-related-quality-of-life-hr-qol-questionnaire-for-hereditary-spastic-paraplegia-hsp-patients-and-caregivers/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/development-of-a-health-related-quality-of-life-hr-qol-questionnaire-for-hereditary-spastic-paraplegia-hsp-patients-and-caregivers/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley